摘要
近年来,润肤剂为干燥性炎症性皮肤病的基础治疗正逐渐成为共识,国际上润肤剂是皮肤病领域中重要的治疗产品,引导患者坚持自我皮肤护理的理念,教会患者居家皮肤护理的方法是确保最佳治疗效果、降低疾病复发频率和复发程度的关键所在。本文就润肤剂在炎症性皮肤病中的临床应用做一综述。
Emollient therapy is the basic treatment for dry inflammatory skin diseases in recent years, which becomes a consensus. Simultaneously emollients are the important therapeutic products in the field of dermatology internationally. Guiding patients to adhere to the concept of self-perpetuating skin care and teaching patients home-based skin care methods are the keys to ensure the optimal treatment effectiveness.Clinical application of emollients in inflammatory skin diseases is reviewed in this paper.
引文
[1] Tanaka A,Matsuda A,Jung K,et al.Ultra-pure soft water ameliorates atopic skin disease by preventing metallic soap deposition in NC/Tnd mice and reduces skin dryness in humans[J].Acta Dermato-Venereologica,2015,95(7):787-791.
[2] Tonia G.Use of emollients in psoriasis management[J].J Community Nurs,2017,31(3):43-48.
[3] Moncrieff G,Cork M,Lawton S,et al.Use of emollients in dry skin conditions:consensus statement[J].Clin Exp Dermatol,2013,38(3):231-238.
[4] Croney S.Treating skin conditions in the community:Know your emollients[J].Br J Community Nurs,2016,21(9):452-456.
[5] Croney S.Choosing an emollient[J].Br J Nurs,2018,27(11):597-598.
[6] Tanya F.Using soap substitutes,bath additives and leave-on emollients[J].J Community Nurs,2016,30(3):29-34.
[7] Rebecca P.Prescribing for children with atopic eczema in primary care[J].Nurse Prescribing,2015,13(7):326-334.
[8] Dyble T,Ashton J.Use of emollients in the treatment of dry skin conditions[J].Br J Community Nurs,2011,16(5):214-220.
[9] Geraghty J.Introducing a new skin-are regimen for the incontinent patient[J].Br J Nurs,2011,20(7):409-415.
[10] Min L,Xia L,Xiaoying C,et al.Topical application of a linoleic acid-ceramide containing moisturizer exhibit therapeutic and preventive benefits for psoriasis vulgaris:a randomized controlled trial[J].Dermatol Therapy,2015,28:373-382.
[11] Moncrieff G,Cork M,Lawton S,et al.Use ofemollientsin dry-skinconditions:consensus statement[J].Clinical & Experimental Dermatol,2013,38(3):231-238.
[12] Kolions AGA,Rusca F,Reisenbauer k,et al.Topical treatment habits in psoriasis patients receiving adalimumab[J].Dermatol,2012,224(3):228-230.
[13] Rebecca Penzer RN,BSc(Hons),PGDipEd,MSc.Principles of Skin Care[M]1st ed.A Macmillan Company,2010:71-83.
[14] Seite S,Khemis A,Rougier A,et al.Emollient for maintenance therapy after topical corticotherapy in mild psoriasis[J].Exp Dermatol,2009,18:1076-1078.
[15] Torsekar R,Gautam MM.Topitcal therapies in psoriasis[J].Indian Dermatol Online,2017,8:235-45.
[16] Nicol N,Boguniewicz M.Successful strategies in atopic dermatitis management[J].Dermatol Nurs,2008,10:3-18.
[17] Joint Formulary Committee.British National Formulary.London:BMJ Group and Pharmaceutical Press,2011:61.
[18] Britton J.The use of emollients and their correct application[J].J Community Nurs,2003,17(9):22-25.
[19] Glatz M,Jo JH,Kennedy EA,et al.Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis[J].PLoS One,2018,13(2):1-17.
[20] Arnd J,Anke M,Matthias A.Keratolytics and Emollients and Their Role in the Therapy of Psoriasis:a Systematic Review[J].Dermatol Ther(Heidelb),2015(5):1-18.